Cancer vaccines: between the idea and the reality
Explore this paper's citation graph
Summary
The common and the unique challenges to cancer vaccines and the progress that has been made in meeting them are addressed.
- Type
- review
- Published
- 2003-08-01
- Cited by
- 649
- References
- 176
- Access
- Open access
- OpenAlex
- https://openalex.org/W1989660541
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:6861735
Keywords
Cancer, Immune system, Medicine, Disease, Adjuvant
References
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
- Innate immunity: Lipoproteins take their Toll on the host
- Dendritic Cell/Peptide Cancer Vaccines: Clinical Responsiveness and Epitope Spreading
- CpG DNA: security code for host defense
- Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma
- Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age.
- Immunotherapy of human cancer: lessons from mice
- MUC1 and breast cancer.
- Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.
- Functional subsets of memory T cells identified by CCR7 expression.
- A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma.
- Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.
- Dendritic cells: On the move from bench to bedside
- Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
- Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection.
- Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1.
- Human tumor antigens are ready to fly.
- Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen.
- Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects.
- Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Cited by
- Novel amphiphilic polyanhydrides for vaccine delivery
- Anti-Cancer Vaccines — A One-Hit Wonder?
- Vaccine Engineering Improved by Hybrid Technology
- Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator
- Cooperative Induction of a Tolerogenic Dendritic Cell Phenotype by Cytokines Secreted by Pancreatic Carcinoma Cells1
- Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine.
- Therapeutic cancer vaccines: current status and moving forward.
- Polyelectrolyte‐Enrobed Cancer Cells in View of Personalized Immune‐Therapy
- Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer
- Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8+ T Cells
- RESPUESTA INMUNE CONTRA LA CÁPSIDE DEL VIRUS DE PAPILOMA HUMANO: BASES PARA EL DESARROLLO DE VACUNAS CONTRA EL CÁNCER CERVICAL UTERINO
- Development and Characterization of an Autologous Whole Cell Breast Cancer Vaccine
- Vaccines: Shoot but don't kill
- Dendritic-Cell (DC)-Based Immunotherapy: Tumor Endothelial Marker 8 (TEM8) Gene Expression of DC Vaccines Correlates with Clinical Outcome
- Oncoantigens for an immune prevention of cancer.
- The direct display of costimulatory proteins on tumor cells as a means of vaccination for cancer immunotherapy.
- mice vaccinated with influenza virus vaccines
- Therapeutic vaccines based on genetically modified Salmonella: a novel strategy in cancer immunotherapy.
- Disruption of Transforming Growth Factor-beta Signaling Using a Small Molecule TGF-beta Receptor Type I Kinase Inhibitor Improves the Efficacy of Dendritic Cell Vaccines
- Marcatura di molecole biologiche a funzione antigenica per lo studio e la caratterizzazione di protocolli di vaccinoterapia in oncologia medica
Related papers
- Research progress of aluminum adjuvant
- Diabetes results from a late change in the autoimmune response of NOD mice.
- Immune Adjuvant Effect of CFNCpG Motif on Antigen of Inactivated BVDV1
- Effect of Adjuvant Release Rate on the Immunogenicity of Nanoparticle-Based Vaccines: A Case Study with a Nanoparticle-Based Nicotine Vaccine
- Adjuvant formulations for experimental vaccines.
- Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant
- Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants